There’s a hot debate taking place over at Dr. Sally Rockey’s blog on NIH Extramural Funding. How, she asks, can NIH “continue to fund outstanding biomedical research during austere times?” As of November 11th, 215 people had responded to proposed solutions: Cap indirect costs or set a flat rate? Limit the number of awards per PI? Reduce award sizes? What do you think? Take a look at the NIH slides showing the outcomes of various scenarios and share your thoughts with Dr. Rockey.